Literature DB >> 17786465

The effect of thalidomide on vascular endothelial growth factor and tumor necrosis factor-alpha levels in retinal ischemia/reperfusion injury.

Semih Aydoğan1, Ulkü Celiker, Peykan Türkçüoğlu, Nevin Ilhan, Nusret Akpolat.   

Abstract

BACKGROUND: To evaluate the effects of thalidomide treatment on the temporal course of TNF-alpha, VEGF production and the histopathological changes in ischemia/reperfusion (I/R) injured guinea pigs retina.
METHODS: Control, ischemia, and thalidomide/ischemia groups including seven animals each were formed. Retinal ischemia was induced in male guinea pigs by cannulating anterior chambers and lifting the bottle to a height of 205 cm for 90 min in the ischemia and thalidomide/ischemia groups. The thalidomide/ischemia group received thalidomide (300 mg/kg/day) via nasogastric tube 24 h before ischemia and during 7 days of reperfusion. Guinea pigs were sacrificed for histopathological examination to evaluate the mean thickness of the inner plexiform layer (IPL), polymorphonuclear leukocyte (PMNL) infiltration, and biochemical analysis of retinal VEGF and TNF-alpha levels by ELISA.
RESULTS: The mean retinal VEGF and TNF-alpha levels of the control, ischemia, and thalidomide/ischemia groups were 10.22 +/- 2.58 and 270.41 +/- 69.77 pg/ml; 35.80 +/- 5.97 and 629.93 +/- 146.41 pg/ml; 19.01 +/- 3.01 and 340.93 +/- 158.26 pg/ml, respectively. The retinal VEGF levels were significantly higher in I/R injured groups. The thalidomide/ischemia group retinal VEGF level was significantly lower versus the ischemia group. The retinal TNF-alpha levels were significantly elevated in the ischemia group, but no difference was observed between the thalidomide/ischemia and control groups. Also, the retinal TNF-alpha level was significantly lower in the thalidomide/ischemia group versus the ischemia group. The mean thickness of IPL and PMNL infiltration showed no difference between the control and thalidomide/ischemia groups. However, there was a significant difference between the control and ischemia groups.
CONCLUSION: Thalidomide treatment decreases PMNL infiltration, retinal edema, VEGF, and TNF-alpha synthesis following I/R injury to the guinea pig retina.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786465     DOI: 10.1007/s00417-007-0663-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  32 in total

1.  THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS.

Authors:  J SHESKIN
Journal:  Clin Pharmacol Ther       Date:  1965 May-Jun       Impact factor: 6.875

Review 2.  Thalidomide as an immunotherapeutic agent: the effects on neutrophil-mediated inflammation.

Authors:  Kozo Yasui; Norimoto Kobayashi; Takashi Yamazaki; Kazunaga Agematsu
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

3.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

Authors:  M Fràter-Schröder; W Risau; R Hallmann; P Gautschi; P Böhlen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.

Authors:  S J Leibovich; P J Polverini; H M Shepard; D M Wiseman; V Shively; N Nuseir
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

5.  Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester.

Authors:  Sekhar Majumdar; Betty Lamothe; Bharat B Aggarwal
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

6.  Increased cytokine gene expression in rat retina following transient ischemia.

Authors:  M Hangai; N Yoshimura; Y Honda
Journal:  Ophthalmic Res       Date:  1996       Impact factor: 2.892

7.  Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion.

Authors:  P Hofman; B C van Blijswijk; P J Gaillard; G F Vrensen; R O Schlingemann
Journal:  Arch Ophthalmol       Date:  2001-06

8.  Effects of thalidomide on neutrophil respiratory burst, chemotaxis, and transmigration of cytokine- and endotoxin-activated endothelium.

Authors:  S Dunzendorfer; P Schratzberger; N Reinisch; C M Kähler; C J Wiedermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-11       Impact factor: 3.000

9.  Inhibitory effects of thalidomide on cellular proliferation, endoneurial edema and myelin phagocytosis during early wallerian degeneration.

Authors:  J M Schröder; B Sellhaus; T Wöhrmann; B Kögel; K Zwingenberger
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Hypoxic regulation of vascular endothelial growth factor in retinal cells.

Authors:  L P Aiello; J M Northrup; B A Keyt; H Takagi; M A Iwamoto
Journal:  Arch Ophthalmol       Date:  1995-12
View more
  7 in total

1.  Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-α in the retina.

Authors:  Shahid Husain; Gregory I Liou; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-20       Impact factor: 4.799

2.  Effect of thalidomide in combination with gemcitabine on human pancreatic carcinoma SW-1990 cell lines in vitro and in vivo.

Authors:  Zhenguo Qiao; Jigang Yuan; Jiaqing Shen; Chao Wang; Zhilong He; Yijia Hu; Muxing Zhang; Chunfang Xu
Journal:  Oncol Lett       Date:  2015-03-20       Impact factor: 2.967

3.  The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.

Authors:  Ronen Rabinowitz; Gabriel Katz; Mordechai Rosner; Sara Pri-Chen; Abraham Spierer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-15       Impact factor: 3.117

4.  Delivery of antioxidant enzyme genes to protect against ischemia/reperfusion-induced injury to retinal microvasculature.

Authors:  Baihua Chen; Sergio Caballero; Soojung Seo; Maria B Grant; Alfred S Lewin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

Review 5.  Anti-angiogenic activity of rPAI-1(23) and vasa vasorum regression.

Authors:  Mary Jo Mulligan-Kehoe
Journal:  Trends Cardiovasc Med       Date:  2013-01-11       Impact factor: 6.677

6.  Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia.

Authors:  Mario Gössl; Jörg Herrmann; Hui Tang; Daniele Versari; Offer Galili; Dallit Mannheim; S Vincent Rajkumar; Lilach O Lerman; Amir Lerman
Journal:  Basic Res Cardiol       Date:  2009-05-21       Impact factor: 17.165

7.  Vascular endothelial growth receptor 1 acts as a stress-associated protein in the therapeutic response to thalidomide.

Authors:  Qin Liu; Tao Yin; Guoping Wang; Fuchun Guo; Yuhong Ou; Yi Li; Yongsheng Wang
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.